Ultrasound News and Research

RSS

Ultrasound is a procedure in which high-energy sound waves are bounced off internal tissues or organs and make echoes. The echo patterns are shown on the screen of an ultrasound machine, forming a picture of body tissues called a sonogram. Also called ultrasonography.

Breast-Specific Gamma Imaging more effective than ultrasound in finding cancers

Results of a study on Breast-Specific Gamma Imaging (BSGI) presented at the annual breast meeting of the American Society of Clinical Oncology in Washington, D.C., showed that BSGI was nearly twice as effective in finding cancers and more than three times as likely to lead to the correct diagnosis when compared to ultrasound.

6 Oct 2010

Innovacell invests 10 million Euros for clinical development

In a new round of financing, shareholders of Innsbruck's Innovacell Biotechnologie AG agreed on September 27th to make 4.3 million Euros worth of fresh capital available to the company. Financing of the current Phase IIb multi-centre study for urocell is thus totally secured," explained CEO Ekkehart Steinhuber.

6 Oct 2010

Focused Ultrasound Surgery Foundation hosts conference to discuss advancements in therapeutic medicine

The Focused Ultrasound Surgery Foundation is hosting the 2nd International Symposium on MR-guided Focused Ultrasound in Chantilly, Virginia from October 17-20. Leading researchers and clinicians from around the world will gather at the three-day scientific conference to present and discuss the latest advancements in one of the most revolutionary and promising areas of therapeutic medicine.

6 Oct 2010

Alma Lasers partners with National Breast Cancer Foundation to combat breast cancer

Alma Lasers, a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications announced today they will be joining the millions of supporters committed to fighting breast cancer through awareness, education and research.

6 Oct 2010

GOPiCE real-time volumetric imaging incorporated in Medison's ultrasound units

ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today announced that Medison, a world-class manufacturer of advanced ultrasound technology, will incorporate ContextVision's volumetric image enhancement tool, GOPiCE® US, into its ultrasound units during the second half of 2010. GOPiCE, the first real-time volumetric filtering software for ultrasound, offers clinicians the ability to see areas never seen before, including anatomies comprised of deep tissue and behind bone.

5 Oct 2010

Walnuts and walnut oil reduce blood pressure during stress: Study

A diet rich in walnuts and walnut oil may prepare the body to deal better with stress, according to a team of Penn State researchers who looked at how these foods, which contain polyunsaturated fats, influence blood pressure at rest and under stress.

4 Oct 2010

CEUS ultrasound offers superior efficacy to CT scans

Contrast-enhanced ultrasound (CEUS) can be used to evaluate and monitor inflammatory bowel disease (IBD) without exposing patients to CT scans or ionizing radiation, according to a report announced today (Friday) at the ICUS Bubble Conference in Chicago.

4 Oct 2010

Celsion presents Phase I/II DIGNITY trial data at 2010 Breast Cancer Symposium

Celsion Corporation announced today that interim data from its Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall (RCW) Breast Cancer were presented at the poster session at the 2010 Breast Cancer Symposium.

3 Oct 2010

Isotechnika announces CONFIRM1 clinical trial results at TCT 2010 Symposium

Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.

3 Oct 2010

Radiologists urge judicious use of radiation-based imaging in children

A CT scan can mean the difference between an accurate and a wrong diagnosis, timely and delayed treatment and, in some cases, life and death. But because CT scans and other tests that use X-ray technology expose the body to often large doses of radiation, their unnecessary, repeated and excessive use may increase cancer risk, especially in children.

30 Sep 2010

Intrauterine devices for treatment of endometrial cancer

Intrauterine devices, originally developed as contraceptives, can also be used to treat and cure cancer of the endometrium according to new research published online in the cancer journal, Annals of Oncology today (Wednesday 29 September). The finding opens the way for young women with the disease, which affects the lining of the womb, to be treated without the need for a hysterectomy, thus preserving their fertility until they have had all the children they want.

29 Sep 2010

Escalon Medical reports 0.2% increase in product revenue for fiscal year 2010

Escalon Medical Corp. today announced results for its fiscal year ended June 30, 2010. Consolidated product revenue from continued operations for fiscal 2010 increased approximately 0.2% to $30,657,000, compared with $30,600,000 in the prior fiscal year.

29 Sep 2010

UCLA develops educational program to train U.S. armed forces in critical combat casualty care

With American troops leaving Iraq and military efforts continuing in Afghanistan, UCLA has helped develop a first-of-its-kind educational program to train U.S. armed forces medical personnel in critical combat casualty care. The program will not only help advance military care, the program's developers say, but civilian care as well.

27 Sep 2010

Study concludes mammography not effective to reduce breast cancer mortality

A new study over the usefulness of mammography confirms what most people in the breast cancer community already know. Mammograms are one tool in the breast cancer cache: better early detection, widespread awareness and more effective treatments all play a role in reducing deaths from the disease, according to Susan G. Komen for the Cure.

27 Sep 2010

Navilyst Medical to distribute VasoNova's VPS central venous catheter navigation technology

VasoNova announced a strategic partnership with Navilyst Medical Inc. today to distribute its VasoNova™ Vascular Positioning System™ VPS™ central venous catheter navigation technology.

24 Sep 2010

Hyland Software announces acquisition of Computer Systems Company

Hyland Software has purchased privately held Computer Systems Company, Inc. (dba The CSC Group), a provider of business and clinical healthcare software and document conversion services. Terms of the transaction were not disclosed.

24 Sep 2010

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.

24 Sep 2010

Center for Prenatal Pediatrics: A comprehensive care center for women and children

NewYork-Presbyterian Hospital/Columbia University Medical Center today announced the opening of The Carmen and John Thain Center for Prenatal Pediatrics. The new unit will provide high-risk pregnant women and their babies the most comprehensive care currently available, all in one location.

24 Sep 2010

Ultrasonix launches new SonixVCR diagnostic ultrasound imaging recording system

Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems is pleased to announce today the introduction of SonixVCR, a software-based innovation that records, stores, and exports entire exams in a standard digital format.

23 Sep 2010

Abbott announces positive results of bioresorbable vascular device at TCT conference

Abbott today announced positive nine-month results from the first 45 patients enrolled in the second stage of the ABSORB trial. At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data from the same 45-patient group, with the rate of major adverse cardiac events (MACE) unchanged at 4.4 percent and no reports of blood clots (thromboses).

23 Sep 2010